BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12480310)

  • 1. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.
    Evrard B; Chiap P; DeTullio P; Ghalmi F; Piel G; Van Hees T; Crommen J; Losson B; Delattre L
    J Control Release; 2002 Dec; 85(1-3):45-50. PubMed ID: 12480310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Solubility of Albendazole in Cyclodextrin Inclusion Complex: A Molecular Modeling Approach and Physicochemical Evaluation.
    de Melo CG; da Costa LAG; Rabello MM; de Albuquerque Wanderley Sales V; Ferreira AS; da Silva PCD; Nishimura RHV; da Silva RMF; de Araújo Rolim L; Neto PJR
    Curr Drug Deliv; 2022; 19(1):86-92. PubMed ID: 34126897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.
    Ehteda A; Galettis P; Chu SW; Pillai K; Morris DL
    Anticancer Res; 2012 Sep; 32(9):3659-66. PubMed ID: 22993303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of albendazole beta-cyclodextrin complexes.
    Castillo JA; Palomo-Canales J; Garcia JJ; Lastres JL; Bolas F; Torrado JJ
    Drug Dev Ind Pharm; 1999 Dec; 25(12):1241-8. PubMed ID: 10612019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
    Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
    Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the complexation of albendazole with cyclodextrins for the design of new antiparasitic formulations.
    Pradines B; Gallard JF; Iorga BI; Gueutin C; Loiseau PM; Ponchel G; Bouchemal K
    Carbohydr Res; 2014 Oct; 398():50-5. PubMed ID: 25240182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep.
    Wu Z; Tucker IG; Razzak M; Yang L; McSporran K; Medlicott NJ
    Int J Pharm; 2010 Sep; 397(1-2):96-102. PubMed ID: 20621175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole.
    García JJ; Bolás F; Torrado JJ
    Int J Pharm; 2003 Jan; 250(2):351-8. PubMed ID: 12527162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole.
    Mukherjee T; Plakogiannis FM
    J Pharm Pharmacol; 2010 Sep; 62(9):1112-20. PubMed ID: 20796189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability.
    Eriksen JB; Christensen SB; Bauer-Brandl A; Brandl M
    J Pharm Sci; 2022 Jun; 111(6):1667-1673. PubMed ID: 34808218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes.
    García-Rodriguez JJ; Torrado J; Bolás F
    Parasite; 2001 Jun; 8(2 Suppl):S188-90. PubMed ID: 11484352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone.
    Bary AR; Tucker IG; Davies NM
    Eur J Pharm Biopharm; 2000 Sep; 50(2):237-44. PubMed ID: 10962233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation.
    Löscher W; Hönack D; Richter A; Schulz HU; Schürer M; Düsing R; Brewster ME
    Epilepsia; 1995 Mar; 36(3):255-61. PubMed ID: 7614909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexation and solubility behavior of albendazole with some cyclodextrins.
    Díaz D; Bernad Bernad MJ; Gracia Mora J; Escobar Llanos CM
    Pharm Dev Technol; 1998 Aug; 3(3):395-403. PubMed ID: 9742560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (13)C and (15)N solid-state NMR studies on albendazole and cyclodextrin albendazole complexes.
    Ferreira MJ; García A; Leonardi D; Salomon CJ; Lamas MC; Nunes TG
    Carbohydr Polym; 2015 Jun; 123():130-5. PubMed ID: 25843843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions.
    Piette M; Evrard B; Frankenne F; Chiap P; Bertholet P; Castagne D; Foidart JM; Delattre L; Piel G
    Eur J Pharm Sci; 2006 Jun; 28(3):189-95. PubMed ID: 16520026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue compatibility and pharmacokinetics of three potential subcutaneous injectables for low-pH drug solutions.
    Wu Z; Tucker IG; Razzak M; McSporran K; Medlicott NJ
    J Pharm Pharmacol; 2010 Jul; 62(7):873-82. PubMed ID: 20636875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy.
    Pillai K; Akhter J; Morris DL
    J Cancer; 2017; 8(6):913-923. PubMed ID: 28529602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.